This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Feb 1;356(5):444-5.

doi: 10.1056/NEJMp068293.

JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications

Ayalew Tefferi¹

Affiliations

PMID: 17267904
DOI: 10.1056/NEJMp068293

Comment

JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications

Ayalew Tefferi. N Engl J Med. 2007.

. 2007 Feb 1;356(5):444-5.

doi: 10.1056/NEJMp068293.

Author

Ayalew Tefferi¹

Affiliation

¹ Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA.

PMID: 17267904
DOI: 10.1056/NEJMp068293

No abstract available

PubMed Disclaimer

Comment on

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR. Scott LM, et al. N Engl J Med. 2007 Feb 1;356(5):459-68. doi: 10.1056/NEJMoa065202. N Engl J Med. 2007. PMID: 17267906 Free PMC article.

Similar articles

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A. Rajnai H, et al. Orv Hetil. 2006 Nov 12;147(45):2175-9. Orv Hetil. 2006. PMID: 17402211 Hungarian.
Low frequency of JAK2 exon 12 mutations in classic and atypical CMPDs.
Ormazábal C, Hurtado C, Aranaz P, Erquiaga I, García-Delgado M, Calasanz MJ, Novo FJ, Vizmanos JL. Ormazábal C, et al. Leuk Res. 2008 Sep;32(9):1485-7. doi: 10.1016/j.leukres.2008.01.002. Epub 2008 Mar 4. Leuk Res. 2008. PMID: 18291525 No abstract available.
An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 era.
Zhang SJ, Li JY. Zhang SJ, et al. Chin Med J (Engl). 2008 Sep 20;121(18):1838-42. Chin Med J (Engl). 2008. PMID: 19080367 No abstract available.
The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Zhan H, Spivak JL. Zhan H, et al. Clin Adv Hematol Oncol. 2009 May;7(5):334-42. Clin Adv Hematol Oncol. 2009. PMID: 19521323 Review.
Clinical applications of molecular haematology: JAK2 in myeloproliferative disorders.
Agarwal MB. Agarwal MB. J Assoc Physicians India. 2007 Jul;55:507-10. J Assoc Physicians India. 2007. PMID: 17907502 Review.

See all similar articles

Cited by

JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein Thrombosis.
Salhotra A, Oo TH. Salhotra A, et al. Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):4-8. doi: 10.1007/s12288-012-0215-2. Epub 2012 Dec 18. Indian J Hematol Blood Transfus. 2014. PMID: 25332520 Free PMC article.
Advancements and Future Directions in Polycythemia Vera Research: A Bibliometric Analysis.
Xavier B. Xavier B. Cureus. 2024 Jun 6;16(6):e61774. doi: 10.7759/cureus.61774. eCollection 2024 Jun. Cureus. 2024. PMID: 38975402 Free PMC article. Review.
Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.
Toogeh G, Ferdowsi S, Naadali F, Alimoghaddam K, Ghavamzadeh A, Shirkoohi R, Ghaffari SH. Toogeh G, et al. Med Oncol. 2011 Dec;28(4):1555-8. doi: 10.1007/s12032-010-9570-8. Epub 2010 May 25. Med Oncol. 2011. PMID: 20499211
Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity.
Li Z, Xing S, Wang S, Ho WT, Zhao ZJ. Li Z, et al. Exp Hematol. 2007 Nov;35(11):1624-32. doi: 10.1016/j.exphem.2007.07.003. Epub 2007 Aug 30. Exp Hematol. 2007. PMID: 17764811 Free PMC article.
Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.
Chu CC, Zhang L, Dhayalan A, Agagnina BM, Magli AR, Fraher G, Didier S, Johnson LP, Kennedy WJ, Damle RN, Yan XJ, Patten PE, Teichberg S, Koduru P, Kolitz JE, Allen SL, Rai KR, Chiorazzi N. Chu CC, et al. Mol Med. 2011;17(11-12):1338-48. doi: 10.2119/molmed.2010.00110. Epub 2011 Sep 21. Mol Med. 2011. PMID: 21953418 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal